Biotechnology Leader Speeds Research with TIBCO Spotfire Enterprise Analytics Platform

TIBCO Spotfire DXP helps Cenix scientists provide fast and accurate analysis of complex data sources

Biotechnology Leader Speeds Research with TIBCO Spotfire Enterprise Analytics Platform

SOMERVILLE, Mass., Feb. 12 /PRNewswire-FirstCall/ -- Spotfire, a division of TIBCO Software Inc. (NASDAQ: TIBX) , today announced that Cenix BioScience, the leading specialist in advanced RNA interference (RNAi)-based research services, is using the TIBCO Spotfire DXP(TM) 2.0 enterprise analytics platform to simplify analysis and deliver faster research to leading international pharmaceutical and biotechnology companies, and academic laboratories worldwide.

"With the TIBCO Spotfire DXP enterprise analytics platform, we can offer our clients faster and more accurate results because our scientists have the ability to mine these complex datasets much faster and in more depth, ask and answer questions on demand, pull information from multiple data sources and integrate new information as it becomes available, said Maria Mirotsou, Group Leader, Cenix BioScience GmbH. "The higher level of validation afforded by our multi-parametric assays allows us to offer superior predictive value regarding the future therapeutic potential of drug candidates developed."

With Spotfire enterprise analytics, Cenix can provide clients direct and highly predictive insights into the cellular functions of analyzed genes so they can accelerate and improve the quality of therapeutic drug discovery and development.

"Cenix's use of TIBCO's Spotfire software is a great example of how organizations can take advantage of its power and flexibility to help them adapt to the ever changing needs of today's life sciences research," said Christian Marcazzo, senior director of Life Sciences Marketing at Spotfire. "By combining and analyzing research information in unprecedented ways, companies like Cenix can create competitive advantages in a highly aggressive marketplace."

The Spotfire enterprise analytics platform enables pharmaceutical, biotechnology, and academic research groups to quickly find and categorize expression patterns. With interactive analysis and high-impact visualization capabilities, users can examine the expression and annotation dimensions of their data and perform a variety of numerical analyses. Users can also collaborate across and outside their organizations. The Spotfire platform's interactive, visual capabilities for data analysis empower scientists to easily see trends, patterns outliers and unanticipated relationships in data with unprecedented speed and adaptability.

About Spotfire

Spotfire, a division of TIBCO Software Inc, is a leading provider of enterprise analytics software for next generation business intelligence. Spotfire offers a visual and interactive experience that helps professionals quickly discover new and actionable insights in information. Distinguished by its speed to insight and adaptability to specific business challenges, Spotfire rapidly reveals unseen threats and new opportunities, creating significant economic value. Spotfire customers include industry leaders among the Global 2000 that have deployed Spotfire analytics to gain an information advantage over their competitors. For more information, visit http://spotfire.tibco.com.

TIBCO, TIBCO Software, TIBCO Spotfire DXP, and Spotfire are trademarks or registered trademarks of TIBCO Software Inc. in the United States and/or other countries. All other product and company names and marks mentioned in this document are the property of their respective owners and are mentioned for identification purposes only.

Contacts: Jim Baptiste Amy Groden-Morrison Davies Murphy Group, Inc. TIBCO Spotfire Division (781) 418-2438 (617) 702-1710 spotfire@daviesmurphy.com amorriso@tibco.com http://www.daviesmurphy.com http://www.spotfire.com

Website: http://www.spotfire.com/




Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.



Copyright © 1996-2007 PR Newswire Association LLC. All Rights Reserved.
A
United Business Media company.